Feedback / Questions
MCC1 TCR - Fred Hutchinson Cancer Research Center, 2seventy bio, Affini-T Therap
https://www.businesswire.com/news/home/20220602005386/en/Clinical-Strategy-for-Enhancing-Affini-T-Therapeutics%E2%80%99-Merkel-Polyoma-Virus-TCR-Therapy-to-be-Presented-at-ASCO-2022/
Jun 2, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next